NCT07524036 Impact of a Nursing Educational Consultation on the Patient's Adherence to Their Post-stroke Care Plan.
| NCT ID | NCT07524036 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Bordeaux |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2026-06-11 |
| Primary Completion | 2028-06-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2026-06-11 with a primary completion date of 2028-06-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective, single-center, randomized study will evaluate the impact of implementing an educational nursing consultation at the end of hospitalisation for stroke patients returning home on overall adherence to stroke-related medication during the 4-month follow-up visit.
Eligibility Criteria
Inclusion Criteria: * Patients admitted to the Neurovascular Unit (UNV) of CHCB for ischemic stroke and/or hemorrhagic stroke confirmed by brain imaging and/or TIA with an ABCD2 score \>5, * Patients whose discharge orientation is a return home * Age ≥ 18 years * NIHSS \< 15 * Montreal Cognitive Assessment (MoCa) \> 21/30 * Free and informed consent signed by the patient. * Person affiliated with or a beneficiary of a social security scheme Exclusion Criteria: * Patients admitted for mechanical thrombectomy, outside the Basque Coast Hospital (CHCB) * Rankin score estimated at discharge ≥ 4 * Patients requiring assistance from a third party at home for the management of their medication or with stroke follow-up at Prado * Patients placed under protection measures
Contact & Investigator
GASSUAN Karine
PRINCIPAL INVESTIGATOR
Centre Hospitalier de la côte Basque
Frequently Asked Questions
Who can join the NCT07524036 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07524036 currently recruiting?
Yes, NCT07524036 is actively recruiting participants. Contact the research team at kgassuan@ch-cotebasque.fr for enrollment information.
Where is the NCT07524036 trial being conducted?
This trial is being conducted at Bayonne, France.
Who is sponsoring the NCT07524036 clinical trial?
NCT07524036 is sponsored by University Hospital, Bordeaux. The principal investigator is GASSUAN Karine at Centre Hospitalier de la côte Basque. The trial plans to enroll 300 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.